AXSM compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

AXSMAxsome Therapeutics, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

AXSMAxsome Therapeutics, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AXSM

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±12.7%▼−5.83%×0.46

Q2 FY26±9.0%▲+3.83%×0.42

Q1 FY26±6.3%▲+8.31%×1.32

Feb 23 '26±7.1%▼−4.88%×0.69

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

= impliedAXSM realized, solidLLY realized, hatchedOne scale, both sides: full bar = 13%× = |realized| ÷ impliedSource: market data

Q1 FY26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

AXSMAxsome Therapeutics, Inc.

132.45▲+2.04%

Mkt cap$7.2BRevenue$260MQ3 FY26Revenue$638MFY25

LLYELI Lilly & Co

1,362.79▼−0.14%

Regular sessionNov 6 '26

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Regular sessionNov 6 '26

AXSMAxsome Therapeutics, Inc.

LLYELI Lilly & Co

132.45▲+2.04%

Price

1,362.79▼−0.14%

$7.2B

Mkt cap

$1.2T

Q3 FY26$260M

Revenue

$24.4BQ3 FY26

FY25$638M

Revenue

$65.2BFY25

AXSM132.45▲+2.04%vsLLY1,362.79▼−0.14%Regular sessionNov 6 '26